Massive Generalized Lymphadenopathy Due to Systemic Lupus Erythematosus
- 1 Department of Medicine, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait
- 2 Department of Medicine (Nephrology), Adan Hospital, Ahmadi City, Kuwait
- 3 Department of Pathology, Adan Hospital, Ahmadi City, Kuwait
- 4 Department of Nuclear Medicine, Adan Hospital, Ahmadi City, Kuwait
Abstract
Background: Massive generalized lymphadenopathy (MGL) as an initial manifestation of systemic lupus erythematosus (SLE) is rare. The Case: A previously healthy 18-year-old man presented with MGL for 1 month. Subsequently, he developed fever, hypertension, fluid overload, and left abdominal pain. He had hemoglobin 89 g/L, serum creatinine 168 umol/L, serum albumin 29 g/L, prolonged activated partial thromboplastin time, heavy proteinuria, and hematuria. Fused PET/CT scanning showed hypermetabolic peripheral and internal MGL with splenic and right kidney infarctions. Autoimmune tests showed very low serum complements 3 and 4 with high titers of ANA 1/640 (N: 1/40) and anti-dsDNA 666 IU/ml (N: < 10). Serological tests for tuberculosis, syphilis, and Epstein-Barr virus were negative. Tests for hypercoagulable states were negative except for lupus anticoagulant and anti-beta2 glycoprotein I antibodies. Lymph node biopsy showed partial effacement of nodal architecture by areas of necrosis surrounded by extensive T-lymphocytic infiltration that lacked vasculitis, caseation, and granulomas. Moreover, his kidney biopsy showed class IV lupus nephritis. Initially, he was treated with intravenous Solumedrol followed by Prednisone as well as Mycophenolate mofetil for a total of 3 months. Subsequently, he received Rituximab infusion to be on a yearly basis. For his coagulopathy, he received Apixaban. He improved within 1 month. By 1 year of follow-up, he remained clinically stable and with normal laboratory as well as radiological testing. In Conclusion: SLE can present with MGL.
- Maini, R. and Nagalli, S. (2023) Adenopathy. StatPearls Publishing.
- Shapira, Y., Weinberger, A. and Wysenbeek, A.J. (1996) Lymphadenopathy in Systemic Lupus Erythematosus. Prevalence and Relation to Disease Manifestations. Clinical Rheumatology , 15, 335-338. https://doi.org/10.1007/bf02230354
- Papachristodoulou, E., Graef, E., Magliulo, D. and Kyttaris, V. (2023) Prevalence and Clinical Significance of Lymphadenopathy and Its Histological Subtypes in Patients with Systemic Lupus Erythematosus: A Retrospective Cohort Study. Rheumatology International , 43, 1277-1286. https://doi.org/10.1007/s00296-023-05331-4
- Smith, L.W., Gelber, A.C. and Petri, M. (2013) Diffuse Lymphadenopathy as the Presenting Manifestation of Systemic Lupus Erythematosus. Journal of Clinical Rheumatology , 19, 397-399. https://doi.org/10.1097/rhu.0b013e3182a6a924
- Petri, M., Orbai, A., Alarcón, G.S., Gordon, C., Merrill, J.T., Fortin, P.R., et al . (2012) Derivation and Validation of the Systemic Lupus International Collaborating Clinics Classification Criteria for Systemic Lupus Erythematosus. Arthritis & Rheumatism , 64, 2677-2686. https://doi.org/10.1002/art.34473
- Makis, W., Ciarallo, A., Gonzalez-Verdecia, M. and Probst, S. (2017) Systemic Lupus Erythematosus Associated Pitfalls on 18F-FDG PET/CT: Reactive Follicular Hyperplasia, Kikuchi-Fujimoto Disease, Inflammation and Lymphoid Hyperplasia of the Spleen Mimicking Lymphoma. Nuclear Medicine and Molecular Imaging , 52, 74-79. https://doi.org/10.1007/s13139-017-0471-z
- Dad, T. and Gilbert, S.J. (2018) Hematuria and Proteinuria. In: Gilbert, S.J. and Weiner, D.E., Eds., National Kidney Foundation ’ s Primer on Kidney Diseases , 7th Edition, Elsevier, 42-50.e1. https://doi.org/10.1016/b978-0-323-47794-9.00005-6
- Aringer, M., Costenbader, K., Daikh, D., Brinks, R., Mosca, M., Ramsey-Goldman, R., et al . (2019) 2019 European League against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis & Rheumatology , 71, 1400-1412. https://doi.org/10.1002/art.40930
- Rout, P., Goyal, A. and Singhal, M. (2025) Antiphospholipid Syndrome. StatPearls Publishing.
- Bajema, I.M., Wilhelmus, S., Alpers, C.E., Bruijn, J.A., Colvin, R.B., Cook, H.T., et al . (2018) Revision of the International Society of Nephrology/Renal Pathology Society Classification for Lupus Nephritis: Clarification of Definitions, and Modified National Institutes of Health Activity and Chronicity Indices. Kidney International , 93, 789-796. https://doi.org/10.1016/j.kint.2017.11.023